DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) issued its earnings results on Thursday. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.48 by $0.02, Briefing.com reports. The business had revenue of $951.00 million for the quarter, compared to analysts' expectations of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The company's quarterly revenue was up .4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.49 EPS. DENTSPLY SIRONA updated its FY 2024 guidance to 1.820-1.860 EPS and its FY24 guidance to $1.82-$1.86 EPS.
DENTSPLY SIRONA Trading Up 3.5 %
Shares of DENTSPLY SIRONA stock traded up $0.60 during trading on Friday, hitting $17.86. The company's stock had a trading volume of 9,705,924 shares, compared to its average volume of 3,115,189. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87. DENTSPLY SIRONA has a 52 week low of $17.21 and a 52 week high of $37.60. The stock has a market cap of $3.62 billion, a price-to-earnings ratio of -8.63, a price-to-earnings-growth ratio of 1.31 and a beta of 1.02. The stock has a 50-day moving average price of $24.68 and a two-hundred day moving average price of $25.86.
Analyst Upgrades and Downgrades
XRAY has been the topic of a number of recent analyst reports. Leerink Partnrs lowered DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research note on Thursday. StockNews.com raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Wednesday. Needham & Company LLC decreased their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating on the stock in a research report on Friday, October 25th. Evercore ISI decreased their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating on the stock in a research report on Tuesday, October 8th. Finally, Stifel Nicolaus decreased their price objective on DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating on the stock in a research report on Thursday, July 18th. Six equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $29.50.
Read Our Latest Stock Report on XRAY
About DENTSPLY SIRONA
(
Get Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
